Technical Analysis for PTCT - PTC Therapeutics, Inc.

Grade Last Price % Change Price Change
grade F 48.03 0.42% 0.20
PTCT closed up 0.42 percent on Monday, August 10, 2020, on 74 percent of normal volume. Its advance stalled at its 200 day moving average, an important long-term support / resistance line.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Up
Historical PTCT trend table...

Date Alert Name Type % Chg
200 DMA Resistance Bearish 0.00%
20 DMA Resistance Bearish 0.00%
Inside Day Range Contraction 0.00%
200 DMA Resistance Bearish 0.42%
20 DMA Resistance Bearish 0.42%
Shooting Star Candlestick Bearish 0.42%
Slingshot Bearish Bearish Swing Setup 0.42%
Multiple of Ten Bearish Other 0.42%
Fell Below 200 DMA Bearish 2.15%
Gilligan's Island Buy Setup Bullish Swing Setup 2.15%

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

PTC Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of orally administered and proprietary small-molecule drugs for patients living with serious and life-threatening conditions, including genetic and neuromuscular disorders, cancer, and infectious diseases. Its approach includes post-transcriptional control, RNA biology, and gene expression modulation by small-molecules. The company has strategic alliances with AstraZeneca; Celgene Corporation; Cystic Fibrosis Foundation; Genzyme Corporation; Gilead; Muscular Dystrophy Association; Merck & Co., Inc.; Parent Project Muscular Dystrophy; Pfizer Inc.; Roche; Spinal Muscular Atrophy Foundation; and Wellcome Trust. PTC Therapeutics, Inc. was founded in 1998 and is based in South Plainfield, New Jersey.
Biotechnology Biopharmaceutical Cancer Life Sciences Infectious Diseases Gene Expression Neurological Disorders Astrazeneca Muscular Dystrophy Spinal Muscular Atrophy Celgene Dystrophy Neurodegenerative Disorders Neuromuscular Disorders

Is PTCT a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 59.89
52 Week Low 30.7923
Average Volume 855,291
200-Day Moving Average 48.81
50-Day Moving Average 50.84
20-Day Moving Average 49.50
10-Day Moving Average 47.66
Average True Range 2.33
ADX 21.44
+DI 22.13
-DI 29.62
Chandelier Exit (Long, 3 ATRs ) 50.67
Chandelier Exit (Short, 3 ATRs ) 51.77
Upper Bollinger Band 55.84
Lower Bollinger Band 43.17
Percent B (%b) 0.38
BandWidth 25.61
MACD Line -1.17
MACD Signal Line -1.11
MACD Histogram -0.0581
Fundamentals Value
Market Cap 1.99 Billion
Num Shares 41.4 Million
EPS -3.05
Price-to-Earnings (P/E) Ratio -15.75
Price-to-Sales 5.48
Price-to-Book 3.95
PEG Ratio 0.73
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 51.08
Resistance 3 (R3) 51.35 50.62 50.57
Resistance 2 (R2) 50.62 49.84 50.48 50.40
Resistance 1 (R1) 49.32 49.36 48.96 49.05 50.23
Pivot Point 48.59 48.59 48.40 48.45 48.59
Support 1 (S1) 47.29 47.81 46.93 47.02 45.83
Support 2 (S2) 46.56 47.33 46.42 45.66
Support 3 (S3) 45.26 46.56 45.49
Support 4 (S4) 44.99